We are live on ! Find out more
SRGA

Surgalign Holdings, Inc. Common Stock

Delisted

SRGA was delisted on the 30th of June, 2023.

106 hedge funds and large institutions have $185M invested in Surgalign Holdings, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 38 increasing their positions, 32 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 32

6% less funds holding

Funds holding: 113106 (-7)

28% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 18

30% less capital invested

Capital invested by funds: $264M → $185M (-$78.7M)

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
106
Holders Change
-7
Holders Change %
-6.19%
% of All Funds
2.3%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
13
Increased
38
Reduced
32
Closed
18
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
MSL
26
Mackay Shields LLC
New York
$870K +$740K +5,138 +304%
RC
27
RBF Capital
California
$851K -$481K -3,343 -33%
Allianz Asset Management
28
Allianz Asset Management
Germany
$758K -$1.44K -10 -0.2%
Two Sigma Investments
29
Two Sigma Investments
New York
$754K -$136K -941 -14%
Deutsche Bank
30
Deutsche Bank
Germany
$711K +$112K +780 +16%
GF
31
Gabelli Funds
New York
$701K -$168K -1,167 -18%
OAM
32
Oxford Asset Management
United Kingdom
$645K -$140K -970 -16%
State Board of Administration of Florida Retirement System
33
State Board of Administration of Florida Retirement System
Florida
$638K +$221K +1,538 +44%
Charles Schwab
34
Charles Schwab
California
$583K +$26.8K +186 +4%
UBS Group
35
UBS Group
Switzerland
$568K +$47.2K +328 +8%
Grantham, Mayo, Van Otterloo & Co (GMO)
36
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
$555K +$254K +1,767 +68%
Citadel Advisors
37
Citadel Advisors
Florida
$554K +$625K +4,343 New
Marshall Wace
38
Marshall Wace
United Kingdom
$542K -$680K -4,719 -53%
Two Sigma Advisers
39
Two Sigma Advisers
New York
$511K +$87.4K +607 +18%
DCM
40
Dupont Capital Management
Delaware
$506K +$572K +3,972 New
SO
41
STRS Ohio
Ohio
$504K +$39.9K +277 +8%
Goldman Sachs
42
Goldman Sachs
New York
$497K +$44.4K +308 +9%
Wells Fargo
43
Wells Fargo
California
$480K +$56.6K +393 +12%
MAP
44
Milestone Advisory Partners
North Carolina
$368K
T. Rowe Price Associates
45
T. Rowe Price Associates
Maryland
$364K +$576 +4 +0.1%
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$363K
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$353K +$13.5K +94 +4%
AllianceBernstein
48
AllianceBernstein
Tennessee
$340K +$28.8K +200 +8%
California Public Employees Retirement System
49
California Public Employees Retirement System
California
$333K -$533K -3,703 -59%
Bank of America
50
Bank of America
North Carolina
$306K +$47.2K +328 +16%

SRGA Hedge Fund Activity: Q2 2019 in Review

106 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q2 2019, worth a combined $185M — down 30% from $264M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of SRGA and 13 opened new positions — a net loss of 5 holders — while 32 trimmed existing stakes and 38 added.

The largest buyer was Wellington Management Group, adding an estimated $7.68M. The largest seller was Russell Investments Group, cutting an estimated $2.83M.

  • 106 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q2 2019, down from 113 in Q1 2019.
  • Funds reported $185M of Surgalign Holdings, Inc. Common Stock stock for Q2 2019, down 30% quarter-over-quarter.
  • 13 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q2 2019 and 18 closed out, a net change of -5 holders.
  • The largest Surgalign Holdings, Inc. Common Stock buyer in Q2 2019 was Wellington Management Group, an estimated $7.68M added.
  • The largest Surgalign Holdings, Inc. Common Stock seller in Q2 2019 was Russell Investments Group, an estimated $2.83M sold.

Based on aggregated 13F filings for Q2 2019.